S&P 500   3,405.51 (-1.73%)
DOW   27,736.08 (-2.12%)
QQQ   283.01 (-0.61%)
AAPL   115.41 (+0.32%)
MSFT   214.10 (-0.99%)
FB   282.98 (-0.64%)
GOOGL   1,615.30 (-1.08%)
AMZN   3,250.75 (+1.45%)
TSLA   422.26 (+0.39%)
NVDA   540.64 (-0.55%)
BABA   311.47 (+0.50%)
CGC   19.21 (-2.64%)
GE   7.47 (-2.10%)
MU   52.35 (-0.95%)
AMD   83.57 (+1.96%)
T   27.34 (-1.73%)
F   8.02 (-1.72%)
ACB   4.49 (-4.06%)
GILD   59.56 (-2.02%)
NFLX   487.98 (-0.06%)
NIO   26.78 (-1.40%)
BA   161.75 (-3.35%)
DIS   125.26 (-2.41%)
S&P 500   3,405.51 (-1.73%)
DOW   27,736.08 (-2.12%)
QQQ   283.01 (-0.61%)
AAPL   115.41 (+0.32%)
MSFT   214.10 (-0.99%)
FB   282.98 (-0.64%)
GOOGL   1,615.30 (-1.08%)
AMZN   3,250.75 (+1.45%)
TSLA   422.26 (+0.39%)
NVDA   540.64 (-0.55%)
BABA   311.47 (+0.50%)
CGC   19.21 (-2.64%)
GE   7.47 (-2.10%)
MU   52.35 (-0.95%)
AMD   83.57 (+1.96%)
T   27.34 (-1.73%)
F   8.02 (-1.72%)
ACB   4.49 (-4.06%)
GILD   59.56 (-2.02%)
NFLX   487.98 (-0.06%)
NIO   26.78 (-1.40%)
BA   161.75 (-3.35%)
DIS   125.26 (-2.41%)
S&P 500   3,405.51 (-1.73%)
DOW   27,736.08 (-2.12%)
QQQ   283.01 (-0.61%)
AAPL   115.41 (+0.32%)
MSFT   214.10 (-0.99%)
FB   282.98 (-0.64%)
GOOGL   1,615.30 (-1.08%)
AMZN   3,250.75 (+1.45%)
TSLA   422.26 (+0.39%)
NVDA   540.64 (-0.55%)
BABA   311.47 (+0.50%)
CGC   19.21 (-2.64%)
GE   7.47 (-2.10%)
MU   52.35 (-0.95%)
AMD   83.57 (+1.96%)
T   27.34 (-1.73%)
F   8.02 (-1.72%)
ACB   4.49 (-4.06%)
GILD   59.56 (-2.02%)
NFLX   487.98 (-0.06%)
NIO   26.78 (-1.40%)
BA   161.75 (-3.35%)
DIS   125.26 (-2.41%)
S&P 500   3,405.51 (-1.73%)
DOW   27,736.08 (-2.12%)
QQQ   283.01 (-0.61%)
AAPL   115.41 (+0.32%)
MSFT   214.10 (-0.99%)
FB   282.98 (-0.64%)
GOOGL   1,615.30 (-1.08%)
AMZN   3,250.75 (+1.45%)
TSLA   422.26 (+0.39%)
NVDA   540.64 (-0.55%)
BABA   311.47 (+0.50%)
CGC   19.21 (-2.64%)
GE   7.47 (-2.10%)
MU   52.35 (-0.95%)
AMD   83.57 (+1.96%)
T   27.34 (-1.73%)
F   8.02 (-1.72%)
ACB   4.49 (-4.06%)
GILD   59.56 (-2.02%)
NFLX   487.98 (-0.06%)
NIO   26.78 (-1.40%)
BA   161.75 (-3.35%)
DIS   125.26 (-2.41%)
Log in
ETR:COP

Compugroup Medical Stock Forecast, Price & News

€73.60
-0.25 (-0.34 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
€72.95
Now: €73.60
€74.35
50-Day Range
€72.40
MA: €76.59
€80.35
52-Week Range
€46.50
Now: €73.60
€81.45
Volume53,272 shs
Average Volume68,245 shs
Market Capitalization$3.95 billion
P/E Ratio60.38
Dividend Yield0.68%
BetaN/A
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks. This segment offers integrated software solutions for customers to manage, analyze, and use medical data; organize business operations; and generate invoices. Its Pharmacy Information Systems segment provides integrated clinical, administrative, and financial software applications for retail pharmacies. This segment also offers in-store and online merchandising programs. The company's Hospital Information Systems segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute hospitals; rehabilitation centers; and social services, including multi-site hospital networks and regional care organizations. Its Health Connectivity Services segment provides solutions that enable pharmaceutical companies to provide information to healthcare providers through software interfaces. This segment also offers clinical decision support systems, and drugs and therapy databases for healthcare providers; and solutions for personal health records, consumer portals, and mobile applications, as well as collects and mediates clinical data for market studies, clinical trials, etc. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical Aktiengesellschaft and changed its name to CompuGroup Medical Societas Europaea in February 2016. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany.
Read More
Compugroup Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.6Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.03 out of 5 stars

Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+49-261-80000
Employees5,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$778.85 million
Cash Flow€6.80 per share
Book Value€11.18 per share

Profitability

Miscellaneous

Market Cap$3.95 billion
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
€73.60
-0.25 (-0.34 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive COP News and Ratings via Email

Sign-up to receive the latest news and ratings for COP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Compugroup Medical (ETR:COP) Frequently Asked Questions

How has Compugroup Medical's stock been impacted by Coronavirus (COVID-19)?

Compugroup Medical's stock was trading at €55.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, COP shares have increased by 33.3% and is now trading at €73.60.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Compugroup Medical?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Compugroup Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Compugroup Medical
.

When is Compugroup Medical's next earnings date?

Compugroup Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Compugroup Medical
.

What price target have analysts set for COP?

5 brokers have issued 12-month price targets for Compugroup Medical's shares. Their forecasts range from €59.00 to €80.00. On average, they anticipate Compugroup Medical's share price to reach €69.80 in the next year. This suggests that the stock has a possible downside of 5.2%.
View analysts' price targets for Compugroup Medical
.

Who are some of Compugroup Medical's key competitors?

What other stocks do shareholders of Compugroup Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Compugroup Medical investors own include Netflix (NFLX), Whiting Petroleum (WLL), NovelStem International (HOLL), Whiting Canadian (KOG), Vaccinex (VCNX), Whiting USA Trust II (WHZT), Microchip Technology (MCHP), NVIDIA (NVDA), Axon Enterprise (AAXN) and Applegreen (APGN).

Who are Compugroup Medical's key executives?

Compugroup Medical's management team includes the following people:
  • Mr. Frank Gotthardt, Chairman of Management Board & CEO (Age 69)
  • Mr. Christian Bartlett Teig, CFO & Member of Management Board (Age 54)
  • Mr. Uwe Eibich, Exec. VP of Telematics & eHealth Platforms and Member of Management Board (Age 57)
  • Mr. Hannes Reichl, Member of Exec. Board
  • Mr. Frank Brecher, Chief Process Officer & Member of Management Board (Age 49)

What is Compugroup Medical's stock symbol?

Compugroup Medical trades on the ETR under the ticker symbol "COP."

What is Compugroup Medical's stock price today?

One share of COP stock can currently be purchased for approximately €73.60.

How big of a company is Compugroup Medical?

Compugroup Medical has a market capitalization of $3.95 billion and generates $778.85 million in revenue each year. Compugroup Medical employs 5,000 workers across the globe.

What is Compugroup Medical's official website?

The official website for Compugroup Medical is www.cgm.com.

How can I contact Compugroup Medical?

Compugroup Medical's mailing address is Maria Trost 21, KOBLENZ, 56070, Germany. The company can be reached via phone at +49-261-80000.

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.